Tirzepatide Prescribing at ROSEBANK SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
1,060
Total Quantity
1,087
NHS Cost
£101.7K
vs National Avg
+445.8%
ROSEBANK SURGERY prescribed 1,060 items of Tirzepatide over the last 12 months at a cost of £101,742 to the NHS. This is 445.8% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
25
Jul 2026
44
Jul 2026
55
Jul 2026
67
Jul 2026
79
Jul 2026
91
Jul 2026
92
Jul 2026
97
Jul 2026
120
Jul 2026
122
Jul 2026
129
Jul 2026
139
Prescribing Details
| Total Items | 1,060 |
|---|---|
| Total Quantity | 1,087 |
| Total NHS Cost | £101,742 |
| Presentations | 8 different forms |
| vs National Average | +445.8% |
Tirzepatide Prescribing Comparison
| This practice | 1,060 items |
|---|---|
| National average per practice | 194 items |
| Difference | +445.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.